GW-5282

N/A

Report date: 2026/04/18 20:00:19
NME

Base Information

Drug NameGW-5282
Drug Alias NameGW5282GW-5282
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistone-lysine N-methyltransferase EZH1 inhibitorsHistone-lysine N-methyltransferase EZH2 inhibitors
TargetsHistone-lysine N-methyltransferase EZH1Histone-lysine N-methyltransferase EZH2
Therapy Area/IndicationsSolid tumoursLymphoma, T-CellLymphoma, Non-Hodgkin
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesGewu Biotechnology (Jiangsu) Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesDizal (Jiangsu) Pharmaceutical Co LtdGewu Biotechnology (Jiangsu) Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumoursLymphoma, T-CellLymphoma, Non-Hodgkin
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A